These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16185184)

  • 1. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature.
    Bickford CL; Spencer AP
    Pharmacotherapy; 2005 Oct; 25(10):1389-95. PubMed ID: 16185184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
    Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
    Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children.
    Ozturk A; Kaya M; Zeyrek D; Ozturk E; Kat N; Ziylan SZ
    Acta Radiol; 2005 Feb; 46(1):112-6. PubMed ID: 15841750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary precipitation during ceftriaxone therapy: frequency and risk factors.
    Soysal A; Eraşov K; Akpinar I; Bakir M
    Turk J Pediatr; 2007; 49(4):404-7. PubMed ID: 18246742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study.
    Bor O; Dinleyici EC; Kebapci M; Aydogdu SD
    Pediatr Int; 2004 Jun; 46(3):322-4. PubMed ID: 15151550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract infection.
    Krzemień G; Książczyk T; Szmigielska A; Bombiński P; Roszkowska-Blaim M; Werner B; Brzewski M
    Dev Period Med; 2015; 19(2):182-5. PubMed ID: 26384120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudolithiasis due to ceftriaxone treatment for meningitis in children: report of 8 cases.
    Araz N; Okan V; Demirci M; Araz M
    Tohoku J Exp Med; 2007 Mar; 211(3):285-90. PubMed ID: 17347554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
    Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: a rare but potentially severe complication.
    Famularo G; Polchi S; De Simone C
    Ann Ital Med Int; 1999; 14(3):202-4. PubMed ID: 10566187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone-Associated Biliary and Cardiopulmonary Adverse Events in Neonates: A Systematic Review of the Literature.
    Donnelly PC; Sutich RM; Easton R; Adejumo OA; Lee TA; Logan LK
    Paediatr Drugs; 2017 Feb; 19(1):21-34. PubMed ID: 27718120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
    Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
    Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sonographic demonstration of pseudo-cholelithiasis after ceftriaxone].
    Barzilai M
    Harefuah; 1994 Sep; 127(5-6):163-5, 215. PubMed ID: 7995584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-associated biliary pseudolithiasis in children.
    Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
    J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
    Murata S; Aomatsu T; Yoden A; Tamai H
    Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult].
    Jung HK; Lee DS
    Korean J Gastroenterol; 2014 Jun; 63(6):378-81. PubMed ID: 24953617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-administration of α-lipoic acid and glutathione is associated with no significant changes in serum bilirubin, alkaline phosphatase or γ-glutamyltranspeptidase levels during the treatment of neuroborreliosis with intravenous ceftriaxone.
    Puri BK; Hakkarainen-Smith JS; Derham A; Monro JA
    J Complement Integr Med; 2015 Sep; 12(3):227-30. PubMed ID: 25968441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
    Zinberg J; Chernaik R; Coman E; Rosenblatt R; Brandt LJ
    Am J Gastroenterol; 1991 Sep; 86(9):1251-4. PubMed ID: 1882806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone-associated gallbladder pseudolithiasis: report of one case.
    Wen HH; Huang YK; Zheng GL
    Acta Paediatr Taiwan; 2004; 45(5):290-2. PubMed ID: 15868813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone-induced biliary sludge in a patient with uncontrolled diabetes.
    Hagiya H; Hasegawa K; Asano K; Otsuka F
    Intern Med; 2014; 53(21):2549-50. PubMed ID: 25366021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.